Insider Profile
Allard, Guy Paul
$LSL
1
Companies Filed At
4
Open-Market Buys (2yr)
$8K
Buy Value (2yr, open-market)
Jul 03, 2026
Most Recent Trade
Currently Accumulating Companies this insider is net-buying on the open market over the last 90 days
$LSL 46
LSL Pharma Group Inc.
$8K · 4 buys
Last buy Jul 02, 2026
Date Company Role Nature Dir. Shares Price Value Score
Jul 03, 2026 $LSL
LSL Pharma Group Inc.
— Comp. Grant Buy 200,000 — — 46
Jul 02, 2026 $LSL
LSL Pharma Group Inc.
— Open Market Buy 500 $0.32 $160 46
Jun 30, 2026 $LSL
LSL Pharma Group Inc.
— Open Market Buy 4,500 $0.31 $1K 46
Jun 18, 2026 $LSL
LSL Pharma Group Inc.
— Open Market Buy 500 $0.31 $155 46
Jun 15, 2026 $LSL
LSL Pharma Group Inc.
— Open Market Buy 19,500 $0.31 $6K 46
Jan 17, 2025 $LSL
LSL Pharma Group Inc.
— Comp. Grant Buy 300,000 — — 46
Nov 04, 2024 $LSL
LSL Pharma Group Inc.
— Other Sell — — — 46
Nov 04, 2024 $LSL
LSL Pharma Group Inc.
— Other Sell — — — 46
Muted rows are plan purchases, compensation grants, or DRIP — not open-market. Confluence Scores reflect the company's current score, not the score at time of trade.
Form55 provides data and analysis for informational purposes only. Nothing on this site constitutes investment advice or a recommendation to buy or sell any security. Past performance is not indicative of future results.